Up to 16 new jobs will be created and a further 14 safeguarded after a sports and health supplement business was granted permission to expand its Staffordshire headquarters.
Sub-4 Health, which is run by former international athlete Clifton Bradeley, has been given the go ahead for plans to build a single-storey unit at its Cellarhead base.
The site will be used by the company's Biobrade business to produce nutraceutical products which supplement diets and treat or prevent disease.
StokeonTrentLive reports that members of Staffordshire Moorlands District Council's planning committee voted unanimously to approve the application - despite the Leek Road site being in the green belt.
Applicant spokesman Rob Duncan said: "The global nutraceutical market is already worth an estimated $230bn and is forecast to reach $340bn by 2024. The UK is an increasingly important player in that market and that is reflected in the rapid growth that Biobrade has seen since its inception in 2018.
"The company is looking to expand its facilities and invest in the infrastructure of the business in order to sustain the growth it has already experienced and to grow that further. The company already employs 14 people and the applicant forecasts this development will serve to increase the number of skilled employees on the site to between 25 and 30 within the next three years."
Mr Duncan added: “Nutraceuticals are dietary supplements that assist in treating and preventing disease and maintaining a healthy lifestyle.
“The manufacturing of the products is a specialised process and involves the mixing of the product blend by a chemical engineer, pressing of the tablets and shipping of the product to the customer. Owing to the specialised nature of nutraceuticals, staff need to have very high levels of training and experience."
Click here to sign up to the daily BusinessLive email
In May 2020, BioBrade secured a £30,000 cash boost from banking-giant HSBC to help facilitate an increasing number of online orders for health supplements during the pandemic.
